J&J faces more lawsuits over all-metal hips; Functional Neuromodulation kicks off DBS trial to treat Alzheimer's;

 @FierceMedDev: The plot thickens in the FDA's surveillance of whistleblowers. More | Follow @FierceMedDev

 @MarkHFierce: Check out the latest preclinical breakthrough news at FierceBiotechResearch. | Follow @MarkHFierce

 @DamianFierce: Mindray Medical rides across-the-board sales growth to a big Q2. More | Follow @DamianFierce

> In Texas, four more plaintiffs have filed lawsuits against Johnson & Johnson's ($JNJ) DePuy unit over its Pinnacle metal-on-metal hip implants. Report

> Functional Neuromodulation launched a clinical trial in the U.S. and Canada that will test deep brain stimulation in patients with mild Alzheimer's disease. Release

> Roche Diagnostics ($RHHBY) is eyeing double-digit growth in India, looking to partner with hospitals and labs to implement its assays. Article

> LabCorp ($LH) has published a validation study of its PCR assay for bacterial vaginosis, available in its NuSwab line of diagnostic tests. Item

> Zynex ($ZXYI), maker of medical devices for electrotherapy and stroke rehabilitation, reported a 19% increase in net revenue for the second quarter, Release

> Teleflex ($TFX) is launching a line of bladeless access ports and closure devices for laparoscopic surgery, designed to make minimally invasive procedures safer and more effective. News

> Researchers are exploring swimming micro-robots that could enable efficient drug delivery. Blog

Biotech News

 @FierceBiotech: Brain signals when 'Special K' will do the trick. More | Follow @FierceBiotech

 @JohnCFierce: Elan now down 12% on bapi fiasco. So does the board have a short list of CEO candidates looking forward to a really tough challenge? | Follow @JohnCFierce

 @RyanMFierce: Not much left at biotech Agennix after talactoferrin failure. More | Follow @RyanMFierce

> Pluristem soars after stem cell drug aids recovery of cancer patient. More

> Bristol-Myers, others track tricky CGRP drug target to beat migraine. Article

> Pfizer, J&J kill PhIII program for key Alzheimer's drug. News

Pharma News

 @FiercePharma: Endo Health's Q2 profits nosedive on Lidoderm patent litigation charge. More | Follow @FiercePharma

> War-torn Syrian drug plants shut down, triggering shortages. Article

> Researchers eye biomarkers for safer Cox inhibitor use. Story

> WSJ: Top FDA officials knew about email surveillance. Report

> J&J faces new marketing probes as Risperdal settlement nears. More

Biotech Research News

> Epilepsy drug boosts brain function in Alzheimer's preclinical tests. News

> HIV viral fragment delivers promising acute liver-failure treatment. Story

> Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy mice. More

> Teva's MLK inhibitor blocks aggressive breast cancer in MSU study. Article

Pharma Manufacturing News

> Manufacturing, pricing problems lead to K-V bankruptcy. Item

> Amneal doubling U.S. capacity, to add 500 jobs. News

> China sweeps in on drug counterfeiters. Report

> Fuji buys DKSH Thailand plant for $53M. News

And Finally... American swimmer and Olympic record-setter Dana Vollmer was diagnosed with a heart rhythm defect at 15, and she and her family decided against getting an implanted cardiac defibrillator. More

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.